Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib vs Standard Chemotherapy in Elderly Ph+ ALL
NCT00199186Phase 2Unknown
- Sponsor
- Universitätsklinikum Frankfurt
- Start
- Mar 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), sponsored by Universitätsklinikum Frankfurt. Status: unknown.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00199186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199186.